Although the number of patient serum available was low (n = 17), these results are meaningful because they are concordant with those reported in CLL, where CSF1 transcripts are significantly more abundant in progressive CLL patients [51]. The gene discussed is CSF1; the disease is B-cell chronic lymphocytic leukemia.